Related Experiment Video
Updated: Jul 21, 2026
05:52
Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
Description of antipanic therapy in a prospective longitudinal study
K A Yonkers1, J M Ellison, D M Shera
1Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas 75235-9101, USA.
Journal of Clinical Psychopharmacology
|June 1, 1996
Summary
A new scale assesses effective psychopharmacologic treatment for panic disorder. Findings reveal suboptimal medication use, with only 54% of highly symptomatic patients receiving optimal care.
Area of Science:
- Psychiatry
- Clinical Psychology
- Pharmacology
Background:
- Panic disorder is a significant mental health condition.
- Effective psychopharmacologic treatments are available.
- Assessing treatment adequacy is crucial for patient outcomes.
Purpose of the Study:
- To introduce a summary scale for evaluating psychopharmacologic treatment in panic disorder.
- To assess the percentage of patients receiving effective treatment in a large, naturalistic study.
- To enable comparison of somatic treatments across different medication classes.
Main Methods:
- Development and application of a summary scale for antipanic therapy levels.
- Analysis of medication data from 492 patients in a longitudinal, naturalistic study.
- Data collected from 11 academic centers reflecting real-world prescribing practices.
Main Results:
- Only 54% of the most symptomatic panic disorder patients received optimal pharmacologic treatment.
- Among less symptomatic patients meeting full diagnostic criteria, 43% received maximal therapy.
- Treatment adequacy varied across patient symptom severity.
Conclusions:
- A significant proportion of panic disorder patients do not receive optimal psychopharmacologic treatment.
- The developed scale can aid in monitoring and improving treatment quality.
- Further research is needed to address treatment gaps in panic disorder management.
Related Concept Videos
01:28Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:21Antipsychotic Drugs: Typical and Atypical Agents
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
01:24Mania and Antimanic Drugs: Overview
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications